Associated Papers
Germline mutations and developmental mosaicism underlying EGFR-mutant lung cancer.
Burr R et al.
Medrxiv : the Preprint Server for Health Sciences, 2023
37808694 (PubMed )
Supplement: media-2.xlsx › Patient_1
Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors.
Wen Y et al.
Frontiers in Pharmacology, 2021
34163353 (PubMed )
Supplement: Table3.XLSX › ICI_CTNNA2
RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma.
Liu B et al.
Frontiers in Oncology, 2021
34367963 (PubMed )
Supplement: Table_3.xlsx › Table_S3
Exome and copy number variation analyses of Mayer-Rokitansky-Küster- Hauser syndrome.
Takahashi K et al.
Human Genome Variation, 2018
30302266 (PubMed )
Supplement: 41439_2018_28_MOESM5_ESM.xlsx › Sheet1
The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing.
Ye L et al.
Nature Communications, 2017
28580939 (PubMed )
Supplement: ncomms15533-s4.xlsx › mutation_list
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.
Li YY et al.
Nature Communications, 2017
28098136 (PubMed )
Supplement: ncomms14121-s10.xlsx › Validation
Select a paper to view details